Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
8.335
Open
8.320
VWAP
8.25
Vol
263.85K
Mkt Cap
800.01M
Low
8.120
Amount
2.18M
EV/EBITDA(TTM)
--
Total Shares
75.48M
EV
1.05B
EV/OCF(TTM)
--
P/S(TTM)
25.18
Abacus Life, Inc. is a vertically integrated alternative asset manager specializing in life insurance products. The Company operates in three segments: Portfolio Servicing, Active Management, and Originations. Its Portfolio Servicing segment provides policy services to customers on a contract basis. Its Active Management segment buys, sells and trades policies and maintenances policies through to death benefit. The Originations segment originates life insurance policy settlements between investors or buyers, who is often the original policy owner. The policies are purchased from owners or other providers through advisors, brokers or directly through the owner. It originates policies through three primary origination channels (Agents/Financial Advisors, Direct-to-Consumers, Life Settlement Brokers) and Third-Party Intermediaries, screens them for eligibility by verifying that the policy is in force, obtaining consents and disclosures, and submitting cases for life expectancy estimates.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q2
50.53M
+79.51%
0.205
+2.5%
44.60M
+53.41%
0.175
-2.78%
Estimates Revision
The market is revising Upward the revenue expectations for Abacus Global Management, Inc. (ABL) for FY2025, with the revenue forecasts being adjusted by 2.47% over the past three months. During the same period, the stock price has changed by 3.00%.
Revenue Estimates for FY2025
Revise Upward
+2.47%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+3.92%
In Past 3 Month
Stock Price
Go Up
+3.00%
In Past 3 Month
2 Analyst Rating
54.73% Upside
Wall Street analysts forecast ABL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ABL is 12.75 USD with a low forecast of 11.50 USD and a high forecast of 14.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
54.73% Upside
Current: 8.240
Low
11.50
Averages
12.75
High
14.00
54.73% Upside
Current: 8.240
Low
11.50
Averages
12.75
High
14.00
Piper Sandler
Crispin Love
Buy
Maintains
$13 → $12
2025-04-08
Reason
Piper Sandler
Crispin Love
Price Target
$13 → $12
2025-04-08
Maintains
Buy
Reason
Piper Sandler lowered the firm's price target on Abacus Global to $11.50 from $13 and keeps an Overweight rating on the shares. The firm notes asset managers have underperformed financials and the broader market in 2025-to-date, and in recent days, following outperformance in 2024. Sentiment and the outlook have shifted dramatically in what was initially believed to be an environment primed for alternative asset managers for deal activity and realizations following the Trump election to one that is now grappling with tariffs, a potential recession and a capital markets window slamming shut, Piper argues. Unfortunately, given the fluidity of the current environment "we will likely finish 1Q25 earnings season with more questions than answers with uncertainty in current policy and impacts to the macro and asset managers unclear," Piper says.
B. Riley Securities
Matt Howlett
Strong Buy
Maintains
$17 → $15
2025-01-07
Reason
B. Riley Securities
Matt Howlett
Price Target
$17 → $15
2025-01-07
Maintains
Strong Buy
Reason
B. Riley analyst Randy Binner lowered the firm's price target on Abacus Life to $15 from $17 and keeps a Buy rating on the shares following a transfer of coverage. The firm is "broadly constructive" on asset managers but brought earnings in for several names and downgraded Victory Capital (VCTR) from Buy to Neutral. For mortgage real estate investment trusts, elevated Treasury and mortgage rates, as well as pockets of credit uncertainty for both commercial real estate and residential, have earnings moving lower across the group, and a downgrade on Ready Capital (RC) from Buy to Neutral. In select specialty finance, Riley remains bullish. Its top long ideas for 2025 are Abacus Life (ABL), Atlanticus Holdings (ATLC), and DigitalBridge (DBRG).
B. Riley Securities
Matt Howlett
Strong Buy
Maintains
$16 → $17
2024-11-25
Reason
B. Riley Securities
Matt Howlett
Price Target
$16 → $17
2024-11-25
Maintains
Strong Buy
Reason
Abacus Life announced the commencement of an underwritten public offering of 12.5M shares of its common stock, including 10M shares of common stock to be sold by the company and 2.5M to be sold by certain stockholders of the company. Abacus intends to use net proceeds of the primary portion of the offering for its operations, including the purchase of life settlement policies, to support its overall business strategy, for working capital purposes, and for general corporate purposes, which may include funding previously announced and future acquisitions and repayment and refinancing of its indebtedness. Abacus will receive no proceeds from the secondary portion of the offering. Piper Sandler & Co., TD Securities, KKR Capital Markets, B. Riley Securities, and SG Americas Securities are acting as joint book-running managers and representatives of the underwriters of the proposed offering.
Piper Sandler
Crispin Love
Buy
Reiterates
$12 → $13
2024-11-08
Reason
Piper Sandler
Crispin Love
Price Target
$12 → $13
2024-11-08
Reiterates
Buy
Reason
Northland Capital Markets
Mike Grondahl
Buy
Initiates
$14
2024-10-24
Reason
Northland Capital Markets
Mike Grondahl
Price Target
$14
2024-10-24
Initiates
Buy
Reason
Northland analyst Mike Grondahl initiated coverage of Abacus Life with an Outperform rating and $13.50 price target. A "leading buyer" of life insurance policies and a vertically integrated alternative asset manager for customers seeking liquidity with a focus on special insurance products, Abacus is "a high margin and high return" business with a "massive, growing, and under penetrated" total addressable market, the analyst tells investors. The firm views Abacus as well-positioned to take advantage of market tailwinds and continue to execute on its go forward strategy, the analyst added.
B. Riley Securities
Matt Howlett
Strong Buy
Reiterates
$15 → $16
2024-08-29
Reason
B. Riley Securities
Matt Howlett
Price Target
$15 → $16
2024-08-29
Reiterates
Strong Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Abacus Life Inc (ABL.O) is 10.71, compared to its 5-year average forward P/E of 5.04. For a more detailed relative valuation and DCF analysis to assess Abacus Life Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
5.04
Current PE
10.71
Overvalued PE
12.69
Undervalued PE
-2.61
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
3.76
Current EV/EBITDA
10.25
Overvalued EV/EBITDA
9.29
Undervalued EV/EBITDA
-1.77
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
1.71
Current PS
4.20
Overvalued PS
4.24
Undervalued PS
-0.82
Financials
Annual
Quarterly
FY2024Q4
YoY :
+836.02%
18.05M
Total Revenue
FY2024Q4
YoY :
+67.43%
-31.15M
Operating Profit
FY2024Q4
YoY :
+198.66%
-19.01M
Net Income after Tax
FY2024Q4
YoY :
+120.00%
-0.22
EPS - Diluted
FY2024Q4
YoY :
+585.83%
-92.18M
Free Cash Flow
FY2024Q4
YoY :
-185.66%
64.26
Gross Profit Margin - %
FY2024Q4
YoY :
+218.75%
-889.61
FCF Margin - %
FY2024Q4
YoY :
-68.09%
-105.30
Net Margin - %
FY2024Q4
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
22.4M
USD
8
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
5
279.6K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
2
469.9K
Volume
Months
6-9
0
0.0
Volume
Months
0-12
2
250.0K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
22.4M
USD
8
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
5
279.6K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
ABL News & Events
Events Timeline
2025-03-27 (ET)
2025-03-27
16:40:34
Abacus Global sees FY25 adjusted net income $70M-$78M
2025-03-27
16:38:49
Abacus Global reports Q4 adjusted EPS 16c, consensus 14c
2025-02-24 (ET)
2025-02-24
08:59:58
Abacus Life announces private exchange of outstanding public warrants
Sign Up For More Events
Sign Up For More Events
News
8.5
04-07NewsfilterAbacus Global Management Well-Positioned Amid Market Volatility
4.5
03-28BenzingaDow Tumbles Over 500 Points; Abacus Global Management Shares Spike Higher
9.5
03-28BenzingaArgan Posts Upbeat Results, Joins KULR Technology, Abacus Global Management, W. R. Berkley And Other Big Stocks Moving Higher On Friday
Sign Up For More News
People Also Watch
OPAL
Opal Fuels Inc
1.730
USD
-0.57%
HNRG
Hallador Energy Co
14.780
USD
+0.61%
EBS
Emergent BioSolutions Inc
5.450
USD
-0.73%
LASR
nLIGHT Inc
7.810
USD
-0.13%
WLDN
Willdan Group Inc
39.400
USD
+2.63%
CMTG
Claros Mortgage Trust Inc
2.430
USD
0.00%
KULR
KULR Technology Group Inc
1.370
USD
+1.48%
TBLD
Thornburg Income Builder Opportunities Trust
17.850
USD
+0.22%
HUMA
Humacyte Inc
1.460
USD
+1.39%
NYMT
New York Mortgage Trust Inc
5.750
USD
+1.95%
FAQ
What is Abacus Life Inc (ABL) stock price today?
The current price of ABL is 8.24 USD — it has decreased -0.36 % in the last trading day.
What is Abacus Life Inc (ABL)'s business?
What is the price predicton of ABL Stock?
What is Abacus Life Inc (ABL)'s revenue for the last quarter?
What is Abacus Life Inc (ABL)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Abacus Life Inc (ABL)'s fundamentals?
How many employees does Abacus Life Inc (ABL). have?